202 related articles for article (PubMed ID: 3050336)
1. [Evaluation of the efficacy and toxicity of local fusidic aid versus oral dicloxacillin in infections of the skin].
Macotela-Ruiz E; Durán Bermúdez H; Kuri Con FJ; Arevalo López A; Villalobos Ibarra JL
Med Cutan Ibero Lat Am; 1988; 16(2):171-3. PubMed ID: 3050336
[TBL] [Abstract][Full Text] [Related]
2. Fusidic acid in skin and soft tissue infections.
Spelman D
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S59-66. PubMed ID: 10528787
[TBL] [Abstract][Full Text] [Related]
3. Fusidic acid in dermatology: an updated review.
Schöfer H; Simonsen L
Eur J Dermatol; 2010; 20(1):6-15. PubMed ID: 20007058
[TBL] [Abstract][Full Text] [Related]
4. [Managing children skin and soft tissue infections].
Moulin F; Quinet B; Raymond J; Gillet Y; Cohen R
Arch Pediatr; 2008 Oct; 15 Suppl 2():S62-7. PubMed ID: 19000857
[TBL] [Abstract][Full Text] [Related]
5. Fusidic acid-resistant Staphylococcus aureus (FRSA) carriage in patients with atopic eczema and pattern of prior topical fusidic acid use.
Sule O; Brown NM; Willocks LJ; Day J; Shankar S; Palmer CR; Burrows NP
Int J Antimicrob Agents; 2007 Jul; 30(1):78-82. PubMed ID: 17475448
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.
Rodriguez-Solares A; Pérez-Gutiérrez F; Prosperi J; Milgram E; Martin A
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():103-9. PubMed ID: 8396081
[TBL] [Abstract][Full Text] [Related]
7. [Use of a new antibacterial preparation, tomicide, in the treatment of patients with pustulous diseases of the skin].
Fedorovskaia RF; Blinkova LP; Butov IuS; Danilova TN; Shakhabiddinov TT
Vestn Dermatol Venerol; 1988; (4):49-51. PubMed ID: 3046163
[No Abstract] [Full Text] [Related]
8. High levels of fusidic acid-resistant Staphylococcus aureus despite restrictions on antibiotic use.
Mitra A; Mohanraj M; Shah M
Clin Exp Dermatol; 2009 Mar; 34(2):136-9. PubMed ID: 18828847
[TBL] [Abstract][Full Text] [Related]
9. Oral beta-lactams applied to uncomplicated infections of skin and skin structures.
Jacobs MR; Jones RN; Giordano PA
Diagn Microbiol Infect Dis; 2007 Mar; 57(3 Suppl):55S-65S. PubMed ID: 17292581
[TBL] [Abstract][Full Text] [Related]
10. Fusidic acid plus betamethasone in infected or potentially infected eczema.
Hjorth N; Schmidt H; Thomsen K
Pharmatherapeutica; 1985; 4(2):126-31. PubMed ID: 3903779
[TBL] [Abstract][Full Text] [Related]
11. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds.
Ulkür E; Oncul O; Karagoz H; Yeniz E; Celiköz B
Burns; 2005 Nov; 31(7):874-7. PubMed ID: 16011879
[TBL] [Abstract][Full Text] [Related]
12. Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.
Parish LC; Jorizzo JL; Breton JJ; Hirman JW; Scangarella NE; Shawar RM; White SM;
J Am Acad Dermatol; 2006 Dec; 55(6):1003-13. PubMed ID: 17097398
[TBL] [Abstract][Full Text] [Related]
13. Once-daily azithromycin in the treatment of adult skin and skin-structure infections.
Amaya-Tapia G; Aguirre-Avalos G; Andrade-Villanueva J; Peredo-González G; Morfín-Otero R; Esparza-Ahumada S; Rodríguez-Noriega E
J Antimicrob Chemother; 1993 Jun; 31 Suppl E():129-35. PubMed ID: 8396084
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
Gisby J; Bryant J
Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346
[TBL] [Abstract][Full Text] [Related]
15. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
[TBL] [Abstract][Full Text] [Related]
16. The safety record of fusidic acid in non-US markets: a focus on skin infections.
Kraus CN; Burnstead BW
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S527-37. PubMed ID: 21546630
[TBL] [Abstract][Full Text] [Related]
17. [Superficial pyoderma requiring oral antibiotic therapy: fusidic acid versus pristinamycin]].
Claudy A;
Presse Med; 2001 Mar; 30(8):364-8. PubMed ID: 11268891
[TBL] [Abstract][Full Text] [Related]
18. Staphylococcal and streptococcal infections of the skin.
Causey WA
Prim Care; 1979 Mar; 6(1):127-39. PubMed ID: 379890
[TBL] [Abstract][Full Text] [Related]
19. Combined antibiotic/corticosteroid cream in the empirical treatment of moderate to severe eczema: friend or foe?
Hon KL; Wang SS; Lee KK; Lee VW; Leung TF; Ip M
J Drugs Dermatol; 2012 Jul; 11(7):861-4. PubMed ID: 22777230
[TBL] [Abstract][Full Text] [Related]
20. Trimethoprim-polymyxin B sulphate cream compared with fusidic acid cream in the treatment of superficial bacterial infection of the skin.
el Mofty M; Harvey SG; Gibson JR; Calthrop JG; Marks P
J Int Med Res; 1990; 18(2):89-93. PubMed ID: 2160379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
